速度与激情6

Tulsa massacre survivor, residents push to boost Black community's prominence, a century after killings_我的网站

A |     More than 100 years after many of Tulsa's Black residents were killed and their businesses were destroyed by white rioters, the community, including a woman who survived the massacre, is still finding ways to rebuild and seek justice.Between May 31 and June 1, 1921, white Tulsa residents set fire and bombed several square blocks of the city, including Greenwood District, which was known as Black Wall Street because of its successful shops and businesses owned by Tulsa's Black residents.An estimated 300 Black residents were killed and thousands were left homeless after the Tulsa massacre, according to historians.Alicia Odewale, a professor of archeology at the University of Tulsa, is leading a project to dig up Greenwood's past and told GMA 3's DeMarco Morgan, a Tulsa native, that she's already made some shocking discoveries."We found bullets and barbed wire next to doll parts next to lined up toys, next to marbles," she said. "They tried to wipe out families and children.""The artifacts are bearing witness to things that we don't have in our history books," she added.Tiffany Crutcher, an activist, said she's been working to raise awareness of what happened and fight for justice. She has traveled to Congress with survivors and their families on multiple occasions to ensure that their stories are never forgotten."They sat there saying, 'We believe we deserve justice. We still believe in America,' even though they've been through the worst times," Crutcher said.In July, an Oklahoma judge dismissed a lawsuit filed by survivors and their families that sought reparations for the massacre. The decision has been appealed by the plaintiff's attorneys.After last week's passing of Hughes Van Ellis at 102, Lessie Benningfield "Mother" Randle, and Viola Fletcher, 109, are now the last of two living survivors.Lawanna Penny, Randle's granddaughter, said she promised her grandmother that even though the reparations suit has been dismissed, she and others wouldn't stop fighting for justice."I told her, 'We're not going anywhere,' she said. "We want to leave a legacy for her to build up North Tulsa, build it up back the way it used to be."Randle turns 109 next month and she told GMA 3 that she has one wish."I would like to see all of my people here…trying to make the situation better," she said. "Bring some of those things to life so people will know that it's really is true, because there's room for a lot more improvement."。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。

Current article:http://7jikuzx.minpinpengcemiuanjiuxuan.pics/h54/sg0uo.html

Published on:07:00:08